| Identification |
| Name: | Angiotensinogen(tetradecapeptide renin substrate), 5-L-isoleucine- (9CI) |
| Synonyms: | Serine,N-[N-[N-[N-(5-L-isoleucineangiotensin I-yl)-L-leucyl]-L-valyl]-L-tyrosyl]-, L-(8CI); 12: PN: WO0069900 SEQID: 661 unclaimed sequence; 14: PN: WO2005037317SEQID: 24 claimed sequence; 19: PN: US6103237 SEQID: 19 unclaimed sequence; 23:PN: WO2008005531 SEQID: 51 unclaimed sequence; 2: PN: US20060043285 SEQID: 2claimed protein; 2: PN: US20080293634 SEQID: 51 unclaimed protein; 30: PN:WO0069900 SEQID: 679 unclaimed sequence; 44: PN: US6479263 SEQID: 44 claimedprotein; 4: PN: US6294367 SEQID: 28 unclaimed sequence; 5-Isoleucineangiotensin I-leucyl-valyl-tyrosyl-serine; 551: PN: US20090175821 SEQID: 661claimed protein; Angiotensinogen tetradecapeptide (5-isoleucine); L-Serine, L-a-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanyl-L-histidyl-L-leucyl-L-leucyl-L-valyl-L-tyrosyl-;Porcine angiotensinogen(1-14); Porcine renin substrate tetradecapeptide |
| CAS: | 20845-02-7 |
| Molecular Formula: | C85H123 N21 O20 |
| Molecular Weight: | 1759.04 |
| Molecular Structure: |
![(C85H123N21O20) Serine,N-[N-[N-[N-(5-L-isoleucineangiotensin I-yl)-L-leucyl]-L-valyl]-L-tyrosyl]-, L-(8CI); 12: PN: ...](https://img1.guidechem.com/chem/e/dict/4/20845-02-7.gif) |
| Properties |
| Water Solubility: | H2O: 0.3 mg/mL, clear, colorless Soluble in 0.1% TFA |
| Solubility: | H2O: 0.3 mg/mL, clear, colorless Soluble in 0.1% TFA |
| Appearance: | White lyophilized powder |
| Storage Temperature: | −20°C |
| Safety Data |
| |
 |
